Literature DB >> 2806236

Phosphorylation of the high-mobility-group-like protein P1 by casein kinase-2.

G M Maelandsmo1, A C Ostvold, S G Laland.   

Abstract

The nuclear protein P1 (molecular mass 53 kDa), found in all mammalian cell types and tissues so far tested, is an excellent substrate for casein kinase-2. The number of phosphate groups on P1 is 20-30/molecule; the phosphorylation sites are distributed throughout the molecule. The phosphate is present as serine phosphate and possibly threonine phosphate. Proteolytic digestion with Staphylococcus aureus V8 protease of 32P-labelled P1 both in vivo and in vitro revealed that casein kinase-2 may be one of the kinases responsible for the phosphorylation in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806236     DOI: 10.1111/j.1432-1033.1989.tb15046.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer.

Authors:  Tianbo Liu; Shu Tan; Ye Xu; Fanling Meng; Chang Yang; Ge Lou
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

2.  NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinoma.

Authors:  Lina Gu; Bairong Xia; Lili Zhong; Yuan Ma; Lei Liu; Liping Yang; Ge Lou
Journal:  Tumour Biol       Date:  2014-05-13

3.  NUCKS overexpression in breast cancer.

Authors:  Yiannis Drosos; Mirsini Kouloukoussa; Anne Carine Østvold; Kirsten Grundt; Nikos Goutas; Dimitrios Vlachodimitropoulos; Sophia Havaki; Panagoula Kollia; Christos Kittas; Evangelos Marinos; Vassiliki Aleporou-Marinou
Journal:  Cancer Cell Int       Date:  2009-08-10       Impact factor: 5.722

4.  MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.

Authors:  Hua Shen; Lin Wang; Xin Ge; Cheng-Fei Jiang; Zhu-Mei Shi; Dong-Mei Li; Wei-Tao Liu; Xiaobo Yu; Yong-Qian Shu
Journal:  Oncotarget       Date:  2016-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.